Back to Market Feed

Product Information

DUPIXENT 200 MG/1.14 ML SYRING is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $1773.2433 per ML under NDC 00024591801. Its NADAC has been published 288 times since Feb 17, 2021.

DUPIXENT 200 MG/1.14 ML SYRING

Dupilumab
$1773.2433per ML

Strength

200 mg/1.14mL

NDC

00024591801

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

DUPILUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761055

On Market Since

10/19/2018

Pharmacological Classes

Antibodies
Monoclonal
Interleukin 4 Receptor alpha Antagonists
Interleukin-4 Receptor alpha Antagonist

Price Statistics

The NADAC for DUPIXENT 200 MG/1.14 ML SYRING has been published 288 times since Feb 17, 2021, and over the history we have for it it has risen 29.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1773.2433 per ML
All-time high$1774.7544 (May 13, 2026)
All-time low$1366.4730 (Feb 17, 2021)
52-week high$1774.7544
52-week low$1688.2989
Median price$1530.5022
Average price$1560.2322
Largest weekly change+6.0% (Jan 11, 2023)
Weeks tracked288
Tracking sinceFeb 17, 2021

Price History

1W

+0.2%

1M

+0.1%

3M

+0.3%

6M

-0.1%

1Y

+4.8%

3Y

+15.9%

5Y

+29.8%

All

+29.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

DUPIXENT 200 MG/1.14 ML PEN
Brand
00024591902•Sanofi-Aventis U.S. LLC
$1778.2754
+0% more

Related Drugs

Same classification

PRALUENT 75 MG/ML PEN
Brand
61755002002•Regeneron Pharmaceuticals, Inc.
$257.7315
per ML
PRALUENT 150 MG/ML PEN
Brand
61755002102•Regeneron Pharmaceuticals, Inc.
$258.0245
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511050101•Amgen Inc.
$281.8058
per ML
REPATHA 140 MG/ML SYRINGE
Brand
72511075001•Amgen Inc.
$281.8058
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511039302•Amgen Inc.
$281.9692
per ML
REPATHA 140 MG/ML SURECLICK
Brand
72511076002•Amgen Inc.
$281.9692
per ML

Frequently asked questions

What is the NADAC price of DUPIXENT 200 MG/1.14 ML SYRING?

The current National Average Drug Acquisition Cost (NADAC) for DUPIXENT 200 MG/1.14 ML SYRING, manufactured by Sanofi-Aventis U.S. LLC, is $1773.2433 per ML (NDC 00024591801), effective Aug 19, 2026.

How has the price of DUPIXENT 200 MG/1.14 ML SYRING changed over time?

Over the history we have for it, the NADAC for DUPIXENT 200 MG/1.14 ML SYRING has risen 29.8%. It has been tracked across 288 weekly CMS publications since Feb 17, 2021.

What are the highest and lowest recorded NADAC prices for DUPIXENT 200 MG/1.14 ML SYRING?

Since Feb 17, 2021, the NADAC for DUPIXENT 200 MG/1.14 ML SYRING has ranged from a low of $1366.4730 (Feb 17, 2021) to a high of $1774.7544 (May 13, 2026), with a median of $1530.5022 per ML.

Are there cheaper alternatives to DUPIXENT 200 MG/1.14 ML SYRING?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DUPIXENT 200 MG/1.14 ML SYRING in a comparable dosage form, but none are currently priced below it.

Who manufactures DUPIXENT 200 MG/1.14 ML SYRING?

DUPIXENT 200 MG/1.14 ML SYRING (NDC 00024591801) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.